AI Verdict
IMCR has stronger fundamentals based on our AI analysis.
IMKTA vs IMCR Fundamental Comparison
| Metric | IMKTA | IMCR |
|---|---|---|
| Revenue | $1.4B | $400.0M |
| Net Income | $28.1M | $-35.5M |
| Net Margin | 2.0% | -8.9% |
| ROE | 1.7% | -9.3% |
| ROA | 1.1% | -3.3% |
| Current Ratio | 3.36x | 4.04x |
| Debt/Equity | 0.30x | 1.15x |
| EPS | N/A | $-0.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMKTA vs IMCR: Frequently Asked Questions
Is IMKTA or IMCR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMCR has stronger fundamentals. IMKTA is rated SELL (72% confidence) while IMCR is rated HOLD (65% confidence). This is not investment advice.
How does IMKTA compare to IMCR fundamentally?
INGLES MARKETS INC has ROE of 1.7% vs Immunocore Holdings plc's -9.3%. Net margins are 2.0% vs -8.9% respectively.
Which stock pays higher dividends, IMKTA or IMCR?
IMKTA has a dividend yield of N/A or no dividend while IMCR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMKTA or IMCR for long term?
For long-term investing, consider that IMKTA has SELL rating with 72% confidence, while IMCR has HOLD rating with 65% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMKTA vs IMCR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMKTA vs IMCR, the AI consensus favors IMCR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.